ARTICLE | Distillery Therapeutics

Cancer

Hongjiang Li

August 16, 2017 6:16 PM UTC

Cell culture studies suggest a stapled peptide inhibitor of the CTNNB1-TCF4 interaction could help treat colorectal cancer. The compound consisted of a stapled peptide that inhibits the CTNNB1-TCF4 in...

Get Unlimited Access

Continue reading with a free trial.

Start a Free Trial Log In

Or Purchase This Article

BCIQ Company Profiles

Max Planck Society

BCIQ Target Profiles

Beta-catenin (CTNNB1)

Transcription factor 4 (TCF4)